Latest filing published 31 Jan 2023 for 康泰生物, €158k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -43.5%Entry CN¥37.28 · Close at T+365 CN¥21.08
- -36.7%Entry CN¥37.93 · Close at T+365 CN¥24.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
陶瑾: trading record in brief
陶瑾, listed as senior executive, appears in our data through filings on 康泰生物 shares, published by SSE / SZSE (CSRC). In total, 2 filings cover trades dated from 18 January 2023 to 31 January 2023.
The open-market record is one-sided, with 2 purchases worth €231k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 31 January 2023 with an open-market purchase (€158k) in 康泰生物. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 陶瑾
Open company profiles for insider transactions, fundamentals and analyst consensus when available.